TCG Crossover Management »

An2 Therapeutics shares owned by TCG Crossover Management

Quarter-by-quarter ownership of An2 Therapeutics (ANTX) shares owned by TCG Crossover Management from 13F filings

Historical chart of TCG Crossover Management investment in An2 Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including An2 Therapeutics held by TCG Crossover Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in An2 Therapeutics by TCG Crossover Management

Quarter filed Position value Share count Share price at filing
2024-06-30 $3.3M 1.6M 2.15
2024-03-31 $5.1M 1.6M 3.25
2023-12-31 $55M 2.7M 20.49
2023-09-30 $43M 2.7M 16.08
2023-06-30 $11M 1.3M 8.50